Home
About
FAQ
History (1)
Auto-SCT for AML in second remission: CALGB study 9620.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Auto-SCT for AML in second remission: CALGB study 9620.
Linker CA, Owzar K, Powell B, Hurd D, Damon LE, Archer LE, Larson RA. Auto-SCT for AML in second remission: CALGB study 9620. Bone Marrow Transplant. 2009 Sep; 44(6):353-9.
View in:
PubMed
subject areas
Adult
Aged
Aging
Antigens, CD34
Antimetabolites, Antineoplastic
Antineoplastic Agents, Phytogenic
Combined Modality Therapy
Cytarabine
Disease-Free Survival
Etoposide
Female
Humans
Ideal Body Weight
Infusions, Intravenous
Leukemia, Myeloid, Acute
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation
Remission Induction
Transplantation, Autologous
Treatment Outcome
Treatment Refusal
Young Adult
authors with profiles
Bayard L. Powell MD